MRK
Merck & Co., Inc.$128.50-0.68% 1D· price as of Jun 30, 8:32 PM+63.01% over 1Y
Compare:MRK
Mkt Cap
$317.4B
P/E
36.2×
Fwd P/E
13.4×
PEG
6.36
P/B
6.9×
P/S
4.8×
EV/EBITDA
12.2×
Beta
0.22
Div Yield
2.6%
Payout
93.5%
ROE
18.9%
Net Margin
13.6%
Short % Flt
1.2%
Inst. Own
82.2%
52-wk low $76.66$128.5052-wk high $130.29
+67.6% above low-1.4% from high
Seasonality — avg monthly return
Strongest Oct 5.4% · weakest Jul -4.1%Jan
+2.0
Feb
-0.3
Mar
+1.9
Apr
-0.5
May
-0.4
Jun
+3.6
Jul
-4.1
Aug
+1.9
Sep
-2.1
Oct
+5.4
Nov
+3.0
Dec
+1.5
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about Merck & Co., Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
MRK — recent news
Loading headlines…
Quality scorecard
vs Pharmaceuticals · 7 peers · percentile rank
58 / 100
Average
ROIC18.8%
67
ROE34.7%
50
Gross margin74.8%
83
Operating margin34.0%
67
FCF yield3.9%
33
Net debt / EBITDA1.2×
50
Percentile vs 7 Pharmaceuticals peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.